This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jonas Brånalt: Inventor in Pharmaceutical Research
Introduction
Jonas Brånalt is an inventor associated with Gothenburg, Sweden, and AstraZeneca AB. His patent work concerns compounds and their potential pharmaceutical applications.
Latest Patents
The supplied information lists one patent for Brånalt: “N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)quinoline-4-carboxamides.” The patent describes compounds of Formula (I), pharmaceutically acceptable salts, pharmaceutical compositions, kits, and manufacturing methods. It also addresses the use of these compounds and salts to treat or prevent conditions mediated by prolyl endopeptidase fibroblast activation protein (FAP).
Career Highlights
Brånalt’s listed patent reflects work on medicinal chemistry and the development of compounds for potential therapeutic use. The supplied information identifies AstraZeneca AB as his company affiliation.
Collaborations
The supplied information names Maria Johansson and Gavin O’Mahony as Brånalt’s coworkers. It does not specify their roles or contributions to the patent.
Conclusion
Jonas Brånalt’s listed invention focuses on quinoline-4-carboxamide compounds and their potential applications in addressing FAP-mediated conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile